TOP2A and breast cancer: Furthermore, Topoisomerase IIα (TOP2A) is O-GlcNAcylated, which promotes malignant tumor progression in breast cancer and resistance to adriamycin by stimulating the binding of TOP2A to chromatin and its topoisomerase activity (11).